- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Justin Bachmann on How Cardiology Is Handling Transition to Value-Based Care
Justin Bachmann, MD, MPH, FACC, instructor of Medicine and Health Policy at Vanderbilt University Medical Center, discusses how cardiologists incorporate value-based care into their procedures.
Justin Bachmann, MD, MPH, FACC, instructor of Medicine and Health Policy at Vanderbilt University Medical Center, discusses how cardiologists incorporate value-based care into their procedures.
Transcript
How is cardiology handling the transition to value-based care and what models are a good fit with cardiology care?
I say we have a little bit of a head start. So cardiology has been involved in value-based care for a while now. We started in the '90s with the development with our registries, specifically the National Cardiovascular Data Registry, which was developed by the American College of Cardiology.
So we have registries that focus on specific procedures, for example PCI or percutaneous coronary intervention, this is soften normally for to as a stent. Also things such as implantable cardioverter defibrillators (ICDs). So these registries collect granular information on patients who are going through these procedures. That really prepared us for that transition so it continued to evolve as bundled payments and episodes of care continue to evolve. I think cardiology will be prepared for that.
A number of the proposed bundled payment models, for example focused on acute myocardio infarction or bypass and those, are a little bit in flux in present, but as these models continue to change and evolve and they’ll continue to do so over the coming years. I think cardiologists will engage with those.
AI, GLP-1s Among Topics to Be Discussed During ASPC Annual Meeting
July 28th 2025The American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease Prevention features multiple sessions on different methods of treating and preventing cardiovascular disease, including through the use of artificial intelligence (AI) and glucagon-like peptide-1 (GLP-1) receptor agonists.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Across 8 Trials, Ruxolitinib Cream Shows Favorable Safety in Pediatric AD
July 25th 2025A poster at the Society for Pediatric Dermatology Annual Meeting presented an integrated safety analysis showing rare or no serious adverse events linked to topical Janus kinase inhibitor use in children with atopic dermatitis (AD).
Read More
